• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov10
Aptevo Therapeutics Showcases APVO451 Preclinical Data
13:06
Nov7
Aptevo Therap released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -40.1338 (forecast USD -37.6199)
04:00
Aptevo Therap released FY2025 9 Months earnings on November 6 (EST), actual revenue USD 0, actual EPS USD -98.5079
04:00
Aug12
Aptevo Therap released FY2025 Q2 earnings on August 11 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -151.2875 (forecast USD -1.498 K)
03:00
Aptevo Therap released FY2025 Semi-Annual earnings on August 11 (EST), actual revenue USD 0, actual EPS USD -30.8373
03:00
Jul9
Aptevo Therapeutics Files Dirk Huebner as Beneficial Owner
21:33

Schedules & Filings

Schedules
Filings
Dec30
Reverse Stock Split(EST)

1-for-18 Reverse Stock Split

Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -9.028 M, EPS -40.1338

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.204 M, EPS -151.2875

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
10.580
+93.77%
+5.120
AEHL
2.180
+92.92%
+1.050
AFJK
82.580
+89.19%
+38.930
PFSA
0.1218
+78.33%
+0.053
DLXY
1.410
+67.86%
+0.570
ULY
2.760
+52.49%
+0.950
MENS
4.220
+51.80%
+1.440
CETX
2.980
+41.23%
+0.870
DAIC
0.5500
+39.06%
+0.154
ONTF
8.060
+37.54%
+2.200
View More